Shortly after, FDA added BPC-157 to its Category 2 Bulk Substance List, designating it as ineligible for compounding for human use
al., 2025
There is no advantage to using the light sensitive forms of cobalamin, such as methylB 12 or adenosylB 12 , instead of the stable cyano or hydroxy forms, which are readily converted in the body into the coenzyme forms, methylB 12 and adenosylB 12
Continuous use advantages include maintaining peak benefits without decline periods, avoiding the uncertainty of whether improvements will persist after breaks, simplifying routine through consistency, and potentially maximizing cumulative collagen synthesis through sustained stimulation over months to years
Main Research Findings 1) Dihexa has therapeutic potential to act as a treatment for various neurological disorders related to reduced synaptic connectivity, such as Alzheimers disease
Scopoletin alleviates toxicity associated with long term exposure to L-DOPA L-DOPA has been the mainstay and most efficacious in management of PD phenotypes